RW

Robert W. Duggan

North America, California, United States, Palo Alto

Description

For over 30 years, Robert W. Duggan has been an expert in corporate planning, capital management and venture capital investments. Before his...

Investor Profile

Robert W. Duggan has backed more than 5 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United Kingdom, United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical Device.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United Kingdom (80%)
  • United States (20%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Therapeutics
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Robert W. Duggan frequently co-invest with?

IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Co-Investments: 1

Which angels does Robert W. Duggan often collaborate with?

JH
North America, Nevada, United States, Incline Village
Shared Deals: 1
MZ
North America, California, United States, Los Altos
Shared Deals: 3

What are some of recent deals done by Robert W. Duggan?

Summit Therapeutics

Abingdon, Oxfordshire, United Kingdom

Summit Therapeutics is a clinical-stage drug discovery and development company.

BiotechnologyHealth CareMedical DeviceTherapeutics
Post Ipo EquitySep 11, 2024
Amount Raised: $235,000,000
Summit Therapeutics

Abingdon, Oxfordshire, United Kingdom

Summit Therapeutics is a clinical-stage drug discovery and development company.

BiotechnologyHealth CareMedical DeviceTherapeutics
Post Ipo EquityJan 30, 2023
Amount Raised: $500,000,000
Summit Therapeutics

Abingdon, Oxfordshire, United Kingdom

Summit Therapeutics is a clinical-stage drug discovery and development company.

BiotechnologyHealth CareMedical DeviceTherapeutics
Post Ipo EquityMay 12, 2021
Amount Raised: $75,000,000
Summit Therapeutics

Abingdon, Oxfordshire, United Kingdom

Summit Therapeutics is a clinical-stage drug discovery and development company.

BiotechnologyHealth CareMedical DeviceTherapeutics
Post Ipo EquityDec 6, 2019
Amount Raised: $50,000,000
CASI Pharmaceuticals

Rockville, Maryland, United States

CASI focus on building a pipeline through mutually beneficial business development transactions.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityMar 20, 2018
Amount Raised: $50,000,000